Jasmin Dam Lukoschewitz’s Post

There’s still time to join us at our Symposium: Heart Failure where we will place emphasis on the importance of a multi-specialty approach to patients with heart failure and will provide an update on contemporary management of heart failure; and also, how this relates to everyday practice in a wide range of patients and clinical settings. Talks and speakers will include: ➡️Four pillars of heart failure treatment - Professor Pardeep Jhund ➡️Device therapies for heart failure - Dr Andrew Flett ➡️Understanding heart failure with preserved ejection fraction (HFpEF) - Dr Alan Japp ➡️The right heart - overlooked and undertreated - Dr Gerry Coghlan ➡️KEYNOTE LECTURE: When is HFpEF not HFpEF? - Professor Marianna Fontana ➡️What is the future of diagnostics in heart failure - Dr Ross Campbell ➡️Management of heart failure in remote and rural areas - Dr Rajiv Sankaranarayanan ➡️Frailty and polypharmacy in heart failure - Dr Rebekkah Schiff ➡️Who and when to refer for advanced HF therapies - Dr Alison Smyth ➡️Delivering equitable palliative care - Professor Miriam Johnson More info and how to book here: https://lnkd.in/e826r-JG #rcpeHF24

Congratulations to Dr. Raymond Benza, MD, on his appointment as Chief of Pulmonary Hypertension at the Mount Sinai Health System. In this role, Dr. Benza will spearhead initiatives to elevate and standardize care for individuals suffering with pulmonary hypertension across our Health System. Pulmonary hypertension, characterized by heightened blood pressure in the lungs, affects approximately one in ten individuals worldwide. Its impact forces the heart to work harder, resulting in distressing symptoms like shortness of breath, chest pain, and dizziness. Unfortunately, patients often overlook these signs, leading to delayed diagnosis and, in severe cases, heart failure. Dr. Benza's vision is clear: 'My aim in this new capacity is to broaden the identification of patients grappling with this frequently undetected condition. By implementing comprehensive assessment strategies and treatment frameworks across our Health System and the New York metro area, our goal is to usher in novel treatment avenues while prioritizing patient well-being. Learn more: https://bit.ly/47o7DpR Raymond L. Benza MD, F.A.C.C., FAHA, FACP

We’re looking forward to our Symposium: Heart Failure on 3 October. This online symposium will place emphasis on the importance of a multi-specialty approach to patients with heart failure and will provide an update on contemporary management of heart failure. We’ll also explore how this relates to everyday practice in a wide range of patients and clinical settings. Talks and speakers will include: ➡️Four pillars of heart failure treatment - Professor Pardeep Jhund ➡️Device therapies for heart failure - Dr Andrew Flett ➡️Understanding heart failure with preserved ejection fraction (HFpEF) - Dr Alan Japp ➡️The right heart - overlooked and undertreated - Dr Gerry Coghlan ➡️KEYNOTE LECTURE: When is HFpEF not HFpEF? - Professor Marianna Fontana ➡️What is the future of diagnostics in heart failure - Dr Ross Campbell ➡️Management of heart failure in remote and rural areas - Dr Rajiv Sankaranarayanan ➡️Frailty and polypharmacy in heart failure - Dr Rebekkah Schiff ➡️Who and when to refer for advanced HF therapies - Dr Alison Smyth ➡️Delivering equitable palliative care - Professor Miriam Johnson More info and how to book here: https://lnkd.in/e826r-JG #rcpeHF24

We’re delighted our Symposium: Heart Failure is open for registration! Join us on 3 October. Our online symposium will place emphasis on the importance of a multi-specialty approach to patients with heart failure and will provide an update on contemporary management of heart failure and how this relates to everyday practice in a wide range of patients and clinical settings. Talks and speakers include: ➡️Four pillars of heart failure treatment - Professor Pardeep Jhund ➡️Device therapies for heart failure - Dr Andrew Flett ➡️Understanding heart failure with preserved ejection fraction (HFpEF) - Dr Alan Japp ➡️The right heart - overlooked and undertreated - Dr Gerry Coghlan ➡️KEYNOTE LECTURE: When is HFpEF not HFpEF? - Professor Marianna Fontana ➡️What is the future of diagnostics in heart failure - Dr Ross Campbell ➡️Management of heart failure in remote and rural areas - Dr Rajiv Sankaranarayanan ➡️Frailty and polypharmacy in heart failure - Dr Rebekkah Schiff ➡️Who and when to refer for advanced HF therapies - Dr Alison Smyth ➡️Delivering equitable palliative care - Professor Miriam Johnson More info and how to book here: https://lnkd.in/e826r-JG #rcpeHF24

Every 5 minutes, someone dies from a lung condition in the UK. And yet there’s a lack of political will to fund the research that could save these lives. Today, the Lung Research and Innovation Group (LRIG) have set out 10 priorities the government and other research funders needs to take seriously to fix the lung research pipeline and fix the nation’s lung health. If the government and other key stakeholders invest in the 10 respiratory research priorities outlined in this report, we will address the largest driver of winter pressures in the NHS, make huge savings for the healthcare system, and serve the needs of the 12 million people in the UK who will develop a lung condition during their lifetime. LRIG is made up of expert organisations and individuals determined to accelerate in lung research and deliver better outcomes for people living with a lung condition. The group is convened by Asthma + Lung UK and co-chaired by Dr Samantha Walker, Director of Research and Innovation at A+LUK, and Professor Ian hall, University of Nottingham. Read and download the report: https://bit.ly/3UtpBTj

Today, the Lung Research and Innovation Group have set out 10 priorities the government needs to take seriously to fix the lung research pipeline and the nation’s lung health.   Currently, people with chronic respiratory conditions face significant challenges, including limited access to effective diagnostic tools for timely diagnosis and monitoring of lung health. As part of our Chronic Respiratory Infection Translational Challenge, we focus on progressing discoveries that can intervene earlier, reduce treatment burden, and enhance the quality of life for individuals with cystic fibrosis and bronchiectasis.

Good to be part of the Lung Innovation and Research Group and to see this important report published. While our Chronic Respiratory Infection Translational Challenge, is focusing on progressing discoveries that can intervene earlier, reduce treatment burden, and enhance the quality of life people living with cystic fibrosis and bronchiectasis, there are common challenges across respiratory conditions. These priorities highlight those challenges and offer solutions to fix the lung research pipeline – now is the time for action. #chronicrespiratoryinfection #lunghealth #lifesciences  #cysticfibrosis #bronchiectasis

An insightful and inspiring report on how to fix lung health in the UK and the top 10 priorities to improve the lives of people living with lung diseases. #lunghealth Asthma + Lung UK

🌟 Exciting News in Heart Failure Treatment! 🌟 🩺 Dr. Lins Junior, MD, from the Federal University of Ceará, brings us an integrative review on Sacubitril/Valsartan in Heart Failure. 🫀 Heart failure affects millions worldwide, but there's hope! Sacubitril/valsartan, a promising therapy, has shown significant benefits in reducing mortality and hospitalizations in patients with reduced left ventricular ejection fraction (LVEF). 🏥 But that's not all! Even patients with preserved LVEF may benefit from this treatment, with a trend towards reducing heart failure hospitalizations. 🌡️ Recent evidence highlights the efficacy and safety of sacubitril/valsartan, suggesting a potential benefit across a wider spectrum of heart failure patients. 🌈 It's time for a breakthrough! Sacubitril/valsartan represents a significant advancement in heart failure treatment, promising improved outcomes for patients. 💪 Let's keep exploring and evolving in the world of heart failure management! 🌍 To find out more, read the attached article. #SacubitrilValsartan #HeartFailureTreatment #MedicalAdvancements #PatientOutcomes 🩺❤️

Calling all cardiac rehabilitation professionals! Have your say on the priorities for the Global Forum in Cardiac Prevention and Rehabilitation! Link below